Menu Back to Event-Details

Panel Discussion

Track:
Can Regulators and HTA Bodies Create Synergies for Patient Access?

Day & Time:
April 18, 4:00PM - 5:30PM (Central Europe Standard Time)

Session Number:
S0103

Type:
Session

Title:
Enhancing Evidence Generation across the Product Life Cycle

Chair(s):
Alison Cave, PhD
Principal Scientific Administrator
European Medicines Agency (EMA), United Kingdom

Description:
Enhancing Evidence Generation across the Product Life Cycle

Presentation(s) & Speaker(s):
Panel Discussion
David Martin, MD, MPH
Associate Director for Real World Evidence Analytics
FDA, United States

Use of Registry Data for Defining Clinical Care Pathways, Unmet Need and the Future – Registry Trails
Edward McKone
Professor, School of Medicine
St. Vincent's University Hospital, Ireland